Proceedings from a daylong multitumor educational webinar in partnership with the Texas Society of Clinical Oncology, featuring key clinical presentations and papers in breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, gynecologic cancers and lung cancer. Featuring perspectives from Drs Thomas A Abrams, John N Allan, Deborah K Armstrong, Arjun Balar, Virginia F Borges, Harold J Burstein, Robert Dreicer, Justin F Gainor, J Randolph Hecht, Corey J Langer, Krishnansu S Tewari, and Sonali M Smith, moderated by Dr Neil Love.

Gynecologic Oncology Update

ASCO Highlights and More: Investigators Review Recent Data Sets and Provide Perspectives on Current Oncology Care

A special audio program developed from the eighth in a series of 11 integrated webinars held in association with the 2021 ONS Annual Congress. Featuring perspectives from Ms Kimberly A Spickes, Ms Paula J Anastasia and Drs Robert L Coleman, Thomas J Herzog and Krishnansu S Tewari.

Oncology Grand Rounds Series: Part 8 — Gynecologic Cancers

Proceedings from an independent satellite symposium during the Society of Gynecologic Oncology’s 2021 Annual Meeting on Women’s Cancer Webinar Series. Featuring perspectives from Drs Susana Banerjee, Richard T Penson and Shannon N Westin, moderated by Neil Love, MD.

Cases from the Community: Investigators Discuss the Role of PARP Inhibition in the Care of Actual Patients with Ovarian Cancer 2021

Featuring perspectives from Drs Michael J Birrer, Kathleen Moore and David M O'Malley, moderated by Neil Love, MD.

What Clinicians Want to Know: Understanding the Factors Affecting the Optimal Diagnosis and Management of Ovarian Cancer 2021

Featuring a discussion on the use of PARP inhibitors in ovarian cancer with Dr Antonio González-Martín, moderated by Dr Neil Love.

Oncology Today with Dr Neil Love: PARP Inhibitors in Ovarian Cancer

Proceedings from a webinar featuring key clinical presentations and papers in gynecologic cancers. Featuring perspectives from Drs Robert L Coleman and Richard T Penson, moderated by Dr Neil Love.

Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Gynecologic Cancers 2020

Featuring a presentation and discussion of recent research on the role of PARP inhibitors and immune checkpoint inhibitors in the management of advanced ovarian cancer with Dr Kathleen Moore, moderated by Dr Neil Love.

Oncology Today with Dr Neil Love: Current and Future Treatment Strategies for Advanced Ovarian Cancer

Featuring a discussion on the evolving role of PARP inhibition in the management of ovarian cancer with Dr Shannon N Westin, moderated by Dr Neil Love.

Oncology Today with Dr Neil Love: The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, lung cancer, lymphomas and chronic lymphocytic leukemia and multiple myeloma. Featuring perspectives from Drs Arjun Balar, Johanna Bendell, Axel Grothey, Brad S Kahl, Shaji K Kumar, Kathleen Moore, Loretta Nastoupil, William K Oh, David M O’Malley, Robert Z Orlowski, Hope S Rugo, Gregory J Riely, David R Spigel and Sara M Tolaney, moderated by Neil Love, MD.

Current Concepts and Recent Advances in Oncology 2020

A special audio program developed from a live webinar produced in conjunction with the 2020 AACR Virtual Annual Meeting. Featuring perspectives from Drs Maha Hussain, Ursula Matulonis, Philip A Philip and Hope S Rugo.

Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers

Featuring a discussion on the current and future role of immune checkpoint inhibitors and other novel therapies in the management of gynecologic cancers with Dr David O’Malley, moderated by Neil Love, MD.

Oncology Today with Dr Neil Love: Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers 2020

A special audio program from a CME webinar held in partnership with the American Society of Clinical Oncology. Featuring perspectives from Drs Mansoor Raza Mirza, Kathleen Moore and Shannon N Westin.

The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer

A special audio program developed from the tenth in a series of 11 integrated webinars held in association with the 2020 ONS Annual Congress. Featuring perspectives from Dr Emmanuel S Antonarakis, Ms Gretchen Santos Fulgencio, Dr Kathleen Moore, Dr Joyce O’Shaughnessy, Dr Michael J Pishvaian and Ms Deborah Wright.

Oncology Grand Rounds Series: Part 10 — PARP Inhibition in the Management of Common Cancers

A special audio program developed from the fifth in a series of 11 integrated webinars held in association with the 2020 ONS Annual Congress. Featuring perspectives from Ms Paula J Anastasia, Ms Jennifer Filipi, Dr David M O’Malley and Dr Shannon N Westin.

Oncology Grand Rounds Series: Part 5 — Gynecologic Cancers

A special audio supplement to a developed from an independent satellite symposium during the Society of Gynecologic Oncology’s 2020 Annual Meeting on Women’s Cancer Webinar Series. Featuring perspectives from Drs Michael J Birrer, Ursula Matulonis, David M O’Malley and Krishnansu S Tewari.

Gyn Onc 2020 Novel Therapies Interviews | Highlights from a discussion with Michael J Birrer, MD, PhD, Ursula Matulonis, MD, David M O’Malley, MD and Krishnansu S Tewari, MD

Featuring one-on-one discussions with leading clinical investigators, this series bridges the gap between research and patient care by providing practicing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.

hubhopper

Gynecologic Oncology Update

hubhopper